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Abstract
The influence of intrauterine environment on the risk of endometriosis is still controversial.
Whether birth weight modifies the risk of endometriosis in adulthood remains an open ques-
tion. For this purpose, we designed a case-control study involving 743 women operated on
for benign gynecological indications from January 2004 to December 2011. Study group in-
cluded 368 patients with histologically proven endometriosis: 54 superficial endometriosis
(SUP), 79 endometriomas (OMA) and 235 deep infiltrating endometriosis (DIE). Control
group included 375 patients without endometriosis as surgically checked. Mean birth
weights were compared between patients and controls, according to endometriosis groups
and rAFS stages. Mean birth weight was significantly lower for patients with endometriosis
as compared to controls (3,119g ± 614 and 3,251g ± 557 respectively; p = 0.002). When
compared to controls, patients with DIE had the lowest birth weight with a highly significant
difference (3,103g ± 620, p = 0.002). In univariate analysis, patients with low birth weight
(LBW), defined as a BW< 2,500g, had a higher risk of endometriosis, especially DIE, as
compared to the reference group (OR = 1.5, 95%CI: 1.0-2.3 and OR = 1.7, 95%CI: 1.0-2.7,
respectively). Multivariate analysis, adjusted on ethnicity and smoking status, showed the
persistence of a significant association between endometriosis and LBW with a slight in-
crease in the magnitude of the association (aOR = 1.7, 95%CI: 1.0-2.6 for endometriosis,
aOR = 1.8; 95%CI: 1.1-2.9 for DIE). In conclusion, LBW is independently associated with
the risk of endometriosis in our population. Among patients with LBW, the risk is almost two-
times higher to develop DIE. This association could reflect common signaling pathways be-
tween endometriosis and fetal growth regulation. There is also the possibility of a role
played by placental insufficiency on the development of the neonate’s pelvis and the occur-
rence of neonatal uterine bleeding that could have consequences on the risk of
severe endometriosis.
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Introduction
In the past few years, we and others identified some epidemiologic markers associated with a higher
risk of endometriosis, including body mass index (BMI) (association between a BMI< 18.5 and
deep infiltrating endometriosis (DIE)) [1] and oral contraceptive pill (especially when indicated for
NSAID-resistant dysmenorrhea) [2,3], but not smoking [4]. These markers may be useful for two
main reasons: (i) they can help to shorten the time required to diagnose and properly handle the
disease. This delay is currently around 8 to 10 years, which is far too long, especially for infertile
women [5]. Gynecologists and general practitioners should ask about these factors to better identify
the patients who are at risk of severe endometriosis [6]; (ii) they provide insight into the disease and
contribute to the development of new treatments.
Endometriosis may be influenced by environmental factors, especially during pregnancy
[7–9]. Prenatal or perinatal exposure to various external influences could induce endometrial
changes in the newborn and promote the development of endometriosis later in life [10]. In
children born with low birth weight (LBW) (i.e. weight at term delivery below 2,500g), the risk
of metabolic syndrome and other vascular diseases in adulthood is well documented. There is
a relationship between LBW and subsequent vascular risk, including metabolic syndrome, car-
diovascular disease, type 2-diabetes and obesity in adulthood. The risk of metabolic syndrome
is ten-times higher in subjects with a birth weight of less than 2,500g, compared to those with
normal birth weight [11]. Young women being born at LBW, irrespective of gestational age, ex-
hibit a reduction in insulin sensitivity and an increased risk of developing clinical and biochem-
ical features of polycystic ovary syndrome [12].
Therefore it seems relevant to study the potential association between birth weight and en-
dometriosis. For this purpose, we designed a case-control study including 368 patients with
histologically confirmed endometriosis and 375 healthy controls in whom the disease was ex-
cluded by surgical examination. Birth weights were collected from medical charts for
each participant.
Materials and Methods
We conducted a case-control study using data extracted from a prospectively managed database,
as previously described [3]. From January 2004 to December 2011, all women younger than
42 years old who were referred to our institution for surgery by operative laparoscopy or laparot-
omy were asked to take part in the study. Exclusion criteria were the followings: (i) normal intra-
uterine pregnancy; (ii) diagnosis of cancer; (iii) incomplete surgical excision of endometriotic
lesions; (iv) absence of histologic confirmation of endometriosis; (v) absence of data on birth
weight. Indications for surgery, sometimes more than one per patient, were as follows: (i) preop-
erative assessment of endometriosis by magnetic resonance imaging and/or ultrasound; (ii) pel-
vic pain, defined as the presence for at least 6 months of dysmenorrhea and/or intermenstrual
pelvic pain and/or dyspareunia of moderate to severe intensity; (iii) infertility defined as at least
12 months of unprotected intercourse not resulting in pregnancy; (iv) pelvic mass (benign ovari-
an cyst, uterine myoma, etc.); (v) others: uterine bleeding, request for tubal ligation, tubal infec-
tion, etc. No specific protocols were used for medical management prior to surgery.
Study group included patients with histologically proven endometriosis. Control group in-
cluded patients without any lesions suggestive of endometriosis as thoroughly checked during
the surgical procedure. Based on histological findings, endometriotic lesions were classified
into three groups: superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA)
and deeply infiltrating endometriosis (DIE) [3]. DIE was defined as endometriotic lesions infil-
trating themuscularis propria of utero-sacral ligament, vagina, bladder, intestine or ureter [13].
As these groups are frequently associated with each other [14], patients were arbitrarily
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classified into the group of the “worst” finding, i.e. from least to worst: SUP, OMA and DIE [4].
The extent of endometriosis was staged during the surgery according to the revised American
Fertility Society (rAFS) classification [15]. Total rAFS score and scores for implants and adhe-
sions were assessed according to the same scoring system.
For each patient, data were recorded one month before surgery in face-to-face interviews
using a previously published questionnaire [4]. We collected general information such as age,
parity, gravidity, body mass index, primary or secondary infertility and its duration, pelvic pain
scores and associated symptoms (dysmenorrhea, deep dyspareunia, non-cyclic chronic pelvic
pain, gastro-intestinal symptoms and lower urinary tract symptoms) and lifestyle habits [3,4].
Birth weights were collected frommaternity records. When the maternity record was not avail-
able, the patient was not included in the study. Women were categorized according to birth weight
into four groups defined as follows: 1,500g, 1,501g—2,500g, 2,501g—4,000g and> 4,000g.
All statistical data were collected in a computerized database. Statistical analysis was per-
formed using STATA 11.0 software (Stata Corp., College Station, Texas, USA). The continuous
data were presented as mean and mean standard deviation. Student’s t-test and ANOVA were
carried out when appropriate. The chi-square or Fischer’s exact tests were used for categorical
data. Average birth weights were first compared for all cases and controls. Then, groups of en-
dometriosis (SUP, OMA and DIE) [16] and disease severity (rAFS classification) [15] were
compared to controls. We performed an unconditional logistic regression to control for poten-
tial confounding factors associated with birth weight and endometriosis risk, such as ethnicity
and smoking status. We computed, in the four intervals of weight ( 1,500g, 1,501g—2,500g,
2,501g—4,000g and> 4,000g), the crude and multivariate adjusted odds ratios (aOR) and the
corresponding 95% confidence intervals (CI) for the risk of endometriosis, SUP, OMA and
DIE compared to the control group. Multivariate models were adjusted on ethnicity and smok-
ing status, assuming ethnicity could be linked both to birth weight and endometriosis, and
smoking status could be linked to smoking status of the parents, and thus to birth weight.
Other variables were not considered as potential confounders. For the analyses, women with
birth weight interval between 2,501g and 4,000g served as the reference population.
A two-sided p-value of 0.05 was considered as statistically significant. The study was ap-
proved by the local institutional review board (IRB approval number 05–2006 given by the
‘Comité de Protection des Personnes et des Biens dans la Recherche Biomédicale’ of Paris Co-
chin) and written informed consent was obtained from all the participating subjects.
Results
A flow chart showing the process of patients’ inclusion is presented as Fig. 1. Control group
included 375 patients without any visual lesion of endometriosis at the time of surgery. Main
indications for surgery in this group, sometimes more than one per patient, were as follows:
myomas (124 patients, 33.1%), ovarian cyst (104 patients, 27.7%), infertility (63 patients,
16.8%), chronic pelvic pain (54 patients, 14.4%), pelvic inflammatory disease (3 patients,
0.8%), ectopic pregnancy (2 patients, 0.5%), ovarian torsion (2 patients, 0.5%) and others
(35 patients, 9.3%). Study group included 368 patients with histologically proven endometri-
osis after complete surgical treatment of the lesions. The distribution of patients according to
the worst lesion was as follows: SUP (54 patients, 14.7%), OMA (79 patients, 21.5%) and DIE
(235 patients, 63.8%). The extent of endometriosis according to the rAFS staging system was
classified according to the following groups: stage I: 61 (16.6%) cases; stage II: 80 (21.7%) cases;
stage III: 83 (22.6%) cases; and stage IV: 144 (39.1%) cases. Mean rAFS scores were distributed
as follows: total: 36.7±32.3, implants: 14.9±12.8 and adhesions: 22.2±25.3. By definition, birth
weights were available for all patients both in study and control groups.
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Baseline characteristics for cases and controls are presented in Table 1. Significant differ-
ences were observed in ethnicity (89.6% patients were Caucasian and 6.3% were Black, in the
endometriosis group, vs. 79.7% and 17.6% in the control group, respectively, p<0.001), body
mass index, parity, gravidity, oral contraceptives use and infertility (Table 1).
Mean birth weights according to the indication for surgery in control group were the follow-
ing: myomas: 3,259g; ovarian cyst: 3,256g; infertility: 3,265g; chronic pelvic pain: 3,246g; emer-
gency (including ectopic pregnancy, tubal infection and ovarian torsion): 3,660g and others:
3,307g. There were no significant differences of birth weight according to the indications for sur-
gery in the control group (p-value = 0.57, chi-square test, patients with multiple indications were
excluded from the statistical analysis). Mean birth weight was significantly lower for patients with
endometriosis as compared to controls (3,119g ± 614 and 3,251g ± 557 respectively; p = 0.002)
(Table 2) and the OR for each 100g more is: OR = 0.96 (95%CI: 0.94–0.99, p = 0.002). Eleven pa-
tients with endometriosis (3.0%) had a birth weight below 1,500g whereas all women in the con-
trol group had a birth weight above 1,500g (Table 2). Mean birth weight was also significantly
different among the endometriosis groups according to the surgical classification (p-value = 0.02
for ANOVA between controls, SUP, OMA, and DIE, Table 2). When comparing SUP to controls
and OMA to controls, the quantitative difference in birth weight did not reach significance:
3,110 g ± 597 and 3,172 g ± 611 vs. 3,251g ± 557 respectively; p = 0.09 for SUP and p = 0.26 for
OMA), but two-by-two comparisons with controls reached significance for all types of endome-
triosis when birth weight was considered in classes (Table 2). Conversely, there were no differ-
ences of birth weight according to the laterality of OMA (left, right or bilateral: 3,228g ± 704,
3,116g ± 539 and 3,133g ± 507 respectively; p = 0.20).
When compared to controls, patients with DIE had the lowest birth weight with a highly
significant difference (3,103g ± 620 vs. 3,251g ± 557, p = 0.002). Among patients with DIE,
there were no differences in birth weight according to the number of deep lesions (one lesion:
3,135g ± 665, two lesions: 3,156g ± 636, three and four lesions: 3,154g ± 569 and more than
five: 3,134g ± 612; p = 0.64) and the main localization (utero-sacral ligaments and vagina:
Fig 1. Flow chart of the study.
doi:10.1371/journal.pone.0117387.g001
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Table 1. Patients’ characteristics between control and endometriosis groups
Endometriosis Controls P-value
N = 368 N = 375
Age (years) a 31.5 ± 5.4 31.6 ± 6.4 0.93 b
Ethnic group (n, %)
Caucasian 327 (89.6) 299 (79.7)
Black 23 (6.3) 66 (17.6)
Asian 8 (2.2) 2 (0.5)
Other 7 (1.9) 8 (2.1) < 0.001 c
Smoking status (n, %)
Never 190 (51.6) 218 (58.1)
Former 55 (14.9) 41 (10.9)
Current 123 (33.4) 113 (30.1) 0.11 c
BMI (kg/m2) a 22.1 ± 4.0 22.7 ± 4.3 0.05 b
Parity a 0.26 ± 0.56 0.44 ± 0.89 0.001 b
Gravidity a 0.54 ± 1.00 0.79 ± 1.26 0.003 b
OC use (n, %)
Never 25 (6.9) 78 (21.0)
Former 263 (72.2) 199 (53.5)
Current 76 (20.9) 95 (25.5) <0.001 c
Infertility (n, %)
No 239 (65.5) 281 (74.9)
Primary 100 (27.4) 62 (16.5)
Secondary 26 (7.1) 32 (8.5) 0.002 c
Infertility as main reason for surgery 40 (10.9) 66 (17.6) 0.009 c
Familial history of endometriosis (n, %) 46 (12.6) 7 (1.9) <0.001 c
rAFS classiﬁcation (n, %) d
I 61 (16.6)
II 80 (21.7)
III 83 (22.6)
IV 144 (39.1)
rAFS scoresa, d
Adhesions 22.2 ± 25.3
Implants 14.9 ± 12.8
Total 36.7 ± 32.3
DIE (n, %) e 235 (63.8)
USL 52 (22.1)
Vagina 19 (8.1)
Bladder 18 (7.7)
Intestine 128 (54.4)
Ureter 18 (7.7)
Number of DIE lesions (n, %)
1–2 125 (53.2)
3–4 68 (28.9)
 5 42 (17.9)
OMA (n, %) 79 (21.5)
Right 25 (31.6)
Left 37 (46.8)
(Continued)
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3,099g ± 739; bladder, intestine and ureter: 3,100g ± 560; p = 0.99). As well, there were no dif-
ferences of birth weight according to the rAFS scoring system.
Results of logistic regression analysis are shown in Table 3. In univariate analysis, patients
with a birth weight below 2,500g had a higher risk of endometriosis, especially DIE, as com-
pared to the reference group (OR = 1.5, 95%CI: 1.0–2.3 and OR = 1.7, 95%CI: 1.0–2.7, respec-
tively). Multivariate analysis, adjusted on ethnicity and smoking status, showed the persistence
of a significant association between endometriosis and the group with a birth weight below
2,500g, with a slight increase in the magnitude of the association (aOR = 1.7, 95%CI: 1.0–2.6).
Patients with a birth weight below 2,500g had also a higher risk of DIE (aOR = 1.8; 95%CI:
1.1–2.9). There was no significant increase in risk for SUP or OMA in this group of patients
with a LBW. Finally, we observed that in the group of women with birth weight> 4,000g, OR
and aOR for endometriosis, for DIE or for OMA were persistently< 1, and mostly 0.5, sug-
gesting a dose-effect relation between birth weight and endometriosis, although it did not
reach significance in any of the three groups.
Table 1. (Continued)
Endometriosis Controls P-value
Bilateral 17 (21.5)
SUP (n, %) 54 (14.7)
a Data are presented as mean ± standard deviation;
b Student t-test;
c chi-square test;
d According to the rAFS classiﬁcation (1985);
e According to a previously published surgical classiﬁcation for deep endometriosis [32].
OC: oral contraceptive; SUP: superﬁcial endometriosis; OMA: endometrioma; DIE: deep inﬁltrating endometriosis; USL: utero-sacral ligament.
doi:10.1371/journal.pone.0117387.t001
Table 2. Distribution of women with endometriosis and controls according to birth weight categories.
Controls Endometriosis P-value SUP P-value OMA P-value DIE P-value Global
P-value
N = 375 N = 368 N = 54 N = 79 N = 235
Mean birth weight a 3,251 ± 557 3,119 ± 614 0.002 b 3,110 ± 597 0.09 b 3,172 ± 611 0.26 b 3,103 ± 620 0.002 b 0.02 c
Birth weight (n, %)
 1,500g 0 (0.0) 11 (3.0) 2 (3.7) 2 (2.5) 7 (3.0)
1,501g—2,500g 37 (9.9) 42 (11.4) 4 (7.4) 8 (10.1) 30 (12.7)
2,501g—4,000g 316 (84.3) 304 (82.6) 48 (88.9) 67 (84.8) 189 (80.4)
> 4,000g 22 (5.9) 11 (3.0) 0.002 d 0 0.006 e 2 (2.5) 0.049 e 9 (3.8) 0.003 d 0.03 f
a Data are presented as mean ± standard deviation;
b Student t-test for two-by-two comparison to controls;
c ANOVA comparing all 4 groups (controls, SUP, OMA and DIE)
d Chi-square test;
e Fischer exact test;
f Fischer exact test comparing all 4 groups of endometriosis (controls, SUP, OMA and DIE), according to birth weight category;
SUP: superﬁcial endometriosis; OMA: endometrioma; DIE: deep inﬁltrating endometriosis
doi:10.1371/journal.pone.0117387.t002
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Discussion
After adjustment for smoking and ethnicity (two factors that possibly influence birth weight),
we observed that women with surgically confirmed and histologically staged endometriosis
had a lower birth weight than controls in which the disease was surgically excluded with an ab-
solute certitude. We found a significant association between DIE and LBW (i.e. weight at term
delivery below 2,500g) while the difference did not reach significance for SUP and OMA. To
the best of our knowledge, this is the first report highlighting a strong association between
LBW and DIE. This result is important as it may help, together with known risk factors (low
BMI, NSAID-resistant dysmenorrhea, OC pill) to discriminate the patients with a higher risk
of severe endometriosis (DIE) and to chose the appropriate imaging work-up.
Our findings are in line with previous reports documenting a positive association between
LBW and endometriosis. In a cohort study of 1,226 cases of laparoscopically-confirmed endo-
metriosis, Missmer et al. reported an increased risk of endometriosis for LBW with a relative
risk of 1.3 (95%CI: 1.0–1.8, p< 0.01) [7]. By contrast, Somigliana et al. failed to detect any as-
sociation between endometriosis and birth weight [8]. These authors recruited 91 women with
a laparoscopic diagnosis of endometriosis and 82 controls who underwent operative laparosco-
py and were free of disease in a case-control study design. It is likely that the small number of
patients enrolled in the study accounted for the negative results, while the strongest association
between endometriosis and birth weight was observed in DIE, which afflicted most of our
patients. The ENDO study reported recently that maternal behaviors during pregnancy and
LBW in particular did not significantly increase the risk of endometriosis (aOR = 1.1; 95%CI:
Table 3. Association between birth weight and endometriosis.
Birth weight (g)  2,500 2,501–4,000 > 4,000
All endometriosis (N = 368)
N (%) 53 (14.4) 304 (82.6) 11 (3.0)
OR (95%CI) 1.49 (0.95–2.33) Reference 0.52 (0.25–1.09)
aOR (95%CI) 1.65 (1.04–2.62) Reference 0.49 (0.23–1.05)
SUP (N = 54)
N (%) 6 (11.1) 48 (88.9) 0
OR (95%CI) 1.07 (0.43–2.66) Reference NA
aOR (95%CI) 1.23 (0.47–3.21) Reference NA
OMA (N = 79)
N (%) 10 (12.7) 67 (84.8) 2 (2.5)
OR (95%CI) 1.27 (0.60–2.69) Reference 0.43 (0.10–1.87)
aOR (95%CI) 1.52 (0.70–3.31) Reference 0.47 (0.10–1.89)
DIE (N = 235)
N (%) 37 (15.8) 189 (80.4) 9 (3.8)
OR (95%CI) 1.67 (1.02–2.73) Reference 0.68 (0.31–1.52)
aOR (95%CI) 1.78 (1.08–2.94) Reference 0.63 (0.28–1.41)
OR: odds ratio;
aOR: adjusted odds ratio; 95%CI: 95% conﬁdence interval;
SUP: superﬁcial endometriosis; OMA: endometrioma; DIE: deep inﬁltrating endometriosis;
Multivariate analysis has been adjusted for ethnicity and smoking status. Women with a birth weight
between 2,501g and 4,000g served as a reference population.
NA: not applicable, no patient in this category.
doi:10.1371/journal.pone.0117387.t003
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0.92–1.32) [9]. However, in this cohort study specifically designed to assess in utero exposures
and endometriosis risk, the proportion of histologically proven endometriosis was very small
(68 patients) and the disease was not categorized into groups such as SUP, OMA and DIE.
Therefore, negative conclusions of the study are certainly not definitive and do not apply to
specific groups of endometriosis, such as DIE which was the most common group in
our population.
Somigliana et al. have nicely depicted the limitations of such observational studies whose
negative effects could be amplified by the long time gap between prenatal exposure and out-
come in adulthood [8]. In our study, assessment of birth weight based on medical records
made our results presumably less exposed to recall bias. While we concede easily with Somigli-
ana that there is no ideal control group for epidemiologic studies on endometriosis, we have
considered that excluding endometriosis at the time of surgery was the best way to undoubted-
ly select healthy controls. Concerning the study group misdiagnoses were highly improbable
because all cases underwent complete excision of all visible endometriotic lesion followed by
a systematic pathologic confirmation. More than 50% of our patients in the study group had ei-
ther stage III or IV, or DIE. This reflected obviously our referral pattern. And concerning the
control group, although they may differ from the endometriosis group in many ways, none of
the conditions affecting the control group was ever reported to be influenced by birth weight.
Consequently, the association found should not be biased by the selection of patients. In this
way our selection criteria for recruiting patients and controls were even more stringent than
those proposed by Holt and Weiss [17].
A limitation to the interpretation of our results is due to the fact that the medical charts we
consulted did not mention the gestational age at delivery, which could obviously influence the
birth weight. In the ENDO study and other studies, preterm delivery was not a risk factor for
endometriosis (OR = 0.98; 95%CI 0.47–2.03) [8,9]. On the contrary, the authors showed that
preterm birth significantly decreased the odds of disease in analyses restricted to visually and
histologically confirmed endometriosis (aOR = 0.41; 95%CI: 0.18–0.94). In other words, it is
probable that the association observed between LBW and endometriosis is due more to intra-
uterine growth restriction than to prematurity.
The influence of intrauterine environment on the risk of endometriosis is still controversial
[18]. In this context the rationale for the association with LBW is unknown. In a mice model
submitted to maternal utero-placental insufficiency, restricted female offspring exhibited
growth restriction associated with biologic abnormalities including elevated triglycerides, uter-
ine endothelial dysfunction and increased uterine artery rigidity [19]. Decreased elasticity of
the pelvic vessels and pathologic development of connective tissue associated with LBWmay
hamper menstrual flow throughout the cervix [20]. This may increase in return the volume of
retrograde menstruation favoring the development of endometriotic lesions [16,21,22]. Anoth-
er hypothesis incriminates the insulin and insulin-like growth factors (IGF) pathways. Data
showed that LBW and intrauterine growth restriction could affect the insulin and IGF axes
around birth [23]. In endometriotic lesions insulin and IGF pathways are altered as compared
to normal endometrium [24,25]. A recent DNA methylation and transcription profiling identi-
fied 23 genes whose methylation levels explained 70–87% of the variance in birth weight [26].
These genes are involved in oxidative stress and insulin signaling, both pathways strongly mod-
ified during endometriosis development [24,27].
The hypothesis has been formulated that neonatal uterine bleeding and endometrial stem/
progenitor cells may play a critical role in the development of early-onset endometriosis and
explain the severity of endometriosis in the adolescent [28,29]. Withdrawal from the maternal
environment of high estrogen and progestogen concentrations at full-term birth may affect the
secretory neonatal endometrium by producing menstruation-like changes. Uterine bleeding
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has been documented to occur from around day 3 for a period of 3 to 5 days and is overt in
3–6% and occult in 25–50% [30]. As stated above, prematurity seems to decrease the risk of en-
dometriosis in adulthood [9]. This finding would be in agreement with the likely absence of
neonatal uterine bleeding in preterm neonates when no secretory changes have occurred. In
contrast, in full-term pregnancies, the neonatal uterine structure with a cervical canal twice the
length of the corpus with thick mucus may favor retrograde menstruation. This may be even
more pronounced if utero-placental insufficiency, reflected by LBW, has hampered the normal
development of pelvic vessels and connective tissue, explaining why LBW seems to positively
influence the development of severe endometriosis. It is important to note that endometrial
changes in 170 newborns as described by Ober and Bernstein (1955) included four cases with
decidual and five cases with menstrual changes. The reported birth weight for the first group
varied between 1,600g and 2,950g and the second group between 2,400g and 3,280g [31].
To conclude, this 743 case-control study provides evidence for an association between LBW
and endometriosis, and especially DIE. While this association could reflect common signaling
pathways between endometriosis and fetal growth regulation, there is also the possibility of
a role played by neonatal uterine bleeding in the risk of severe endometriosis.
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